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Abstract
Background: The benefits of zinc or multiple micronutrient supplementations in African children are uncertain. 
African children may differ from other populations of children in developing countries because of differences in the 
prevalence of zinc deficiency, low birth weight and preterm delivery, recurrent or chronic infections such as HIV, or the 
quality of complementary diets and genetic polymorphisms affecting iron metabolism.
The aim of this study was to ascertain whether adding zinc or multiple micronutrients to vitamin A supplementation
improves longitudinal growth or reduces prevalence of anemia in children aged 6-24 months.
Methods: Randomized, controlled double-blinded trial of prophylactic micronutrient supplementation to children 
aged 6-24 months. Children in three cohorts - 32 HIV-infected children, 154 HIV-uninfected children born to HIV-
infected mothers, and 187 uninfected children born to HIV-uninfected mothers - were separately randomly assigned to 
receive daily vitamin A (VA) [n = 124], vitamin A plus zinc (VAZ) [n = 123], or multiple micronutrients that included 
vitamin A and zinc (MM) [n = 126].
Results: Among all children there were no significant differences between intervention arms in length-for-age Z scores 
(LAZ) changes over 18 months. Among stunted children (LAZ below -2) [n = 62], those receiving MM had a 0.7 Z-score 
improvement in LAZ versus declines of 0.3 in VAZ and 0.2 in VA (P = 0.029 when comparing effects of treatment over 
time). In the 154 HIV-uninfected children, MM ameliorated the effect of repeated diarrhea on growth. Among those 
experiencing more than six episodes, those receiving MM had no decline in LAZ compared to 0.5 and 0.6 Z-score 
declines in children receiving VAZ and VA respectively (P = 0.06 for treatment by time interaction). After 12 months, 
there was 24% reduction in proportion of children with anemia (hemoglobin below 11 g/dL) in MM arm (P = 0.001), 
11% in VAZ (P = 0.131) and 18% in VA (P = 0.019). Although the within arm changes were significant; the between-
group differences were not significant.
Conclusions: Daily multiple micronutrient supplementation combined with vitamin A was beneficial in improving 
growth among children with stunting, compared to vitamin A alone or to vitamin A plus zinc. Effects on anemia require 
further study.
Trial registration: This study is registered with ClinicalTrials.gov, number .NCT00156832.
Background
An estimated 12% of South African children below five
years of age are underweight, and 25% are stunted[1].
Additionally, a high prevalence of vitamin and mineral
deficiency exists in infants and young children, and sur-
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veys have found a 21% prevalence of anemia [2-4].
Despite this, a recent trial of multiple micronutrients in
infants aged six to twelve months was unable to demon-
strate an effect on length-for-age Z-scores, with supple-
mented children continuing to show a decline in Z-scores
over time[5]. The effect of prophylactic zinc and/or addi-
tional micronutrients on growth in this population
remains to be fully defined.
Zinc supplementation is known to improve growth in
certain populations of children. A meta-analysis of zinc
supplementation trials found significant beneficial effects
on height in children, with the largest benefit occurring
in children with low height Z-scores at baseline[6]. Nota-
bly, none of the three trials from African countries
included in the meta-analysis of effect on height found an
improvement in height velocity with zinc supplementa-
tion. This may be related to lesser degrees of stunting in
the African populations compared to Asian populations
where the majority of studies finding benefit were con-
ducted. A more recent trial in Burkina Faso, conducted
after the meta-analysis was conducted, found no benefit
of zinc on height in infants, even in the subgroup of
stunted infants[7]. This raises the question of whether
concurrent deficiencies of other micronutrients limited
the response to zinc. The previous South African study of
infants aged six to twelve months, which failed to find an
effect on length-for-age Z-scores, did not examine effects
in stunted children[5]. Further investigation is therefore
needed to assess the benefits of multiple micronutrient
supplementation in African children, especially those at
highest risk of growth faltering such as those living in
rural areas and those at risk of repeated diarrheal illness.
Anemia in infants and children is multifactorial in ori-
gin. While iron deficiency is the most common cause,
deficiencies in other nutrients that contribute to iron
homeostasis - riboflavin, folic acid, vitamins B12, C and A
- may also result in anemia[8]. The high phytate content
of weaning diets such as maize porridge, the staple food
for rural South African children, may further impair
absorption of iron and zinc. Infectious disease, especially
chronic infection, is known to alter iron metabolism. This
multifactorial nature of anemia may partly explain the
incomplete response of anemia to iron supplementation
in some settings[9,10]. Some trials of multiple micronu-
trients, including the combination of iron and zinc, have
found them more effective in reducing anemia prevalence
than iron alone, [4,9,11,12] while others have not found a
beneficial effect of combined supplementation[13].
Because of these discordant results, the utility of zinc or
multiple micronutrients in preventing anemia or aug-
menting its treatment needs further investigation.
In HIV-infected children early viremia and subsequent
disease progression are superimposed on the other fac-
tors that contribute to growth faltering and anemia in
uninfected children. Poor longitudinal growth becomes
apparent early in infancy. Unlike weight, height fails to
respond to increased feeding[14]. It is conceivable that
infected children may show a suboptimal response to
supplements due to altered metabolism of these nutrients
and reduction in erythropoiesis [15] or the direct effect of
HIV itself[16].
We analyzed data from a randomized, controlled, dou-
ble-blinded community-based trial whose primary aims
were to assess the benefit of prophylactic daily zinc or
multiple micronutrient supplements, both combined
with vitamin A, in comparison to vitamin A alone that
was used as a control group, on: 1) the primary preven-
tion of respiratory illness and diarrhea, and 2) the effect
on growth in rural South African children[17]. Supple-
ments used in this trial had no overall effect on prevalent
days or incidence of diarrhea compared to vitamin A that
was used as a control group, [17] but they reduced the
incidence of diarrhea in stunted children[18].
The main purpose of this analysis is to report on the
second study aim - effect of supplementation on growth -
and to report exploratory analyses of the effect of supple-
mentation on anemia. More specifically, the second aim
of this trial was to compare the effect on longitudinal
length-for-age Z-scores of adding either zinc alone or in
combination with multiple micronutrients to vitamin A
supplements, and to describe how HIV, stunting and
diarrheal morbidity affect the longitudinal growth
response.
Methods
Study site, population and design
The study was a randomized, controlled double-blinded
community-based trial of prophylactic zinc supplements,
or multiple micronutrient supplements including zinc,
given to three cohorts of children starting at age 6
months and continuing until age 24 months[17]. The trial
was performed in a non-malaria endemic area in rural
northern KwaZulu-Natal Province, South Africa during
2003 to 2006. Most infants in this area received breast
and complementary feeding early in infancy[19]; in the
study sample we found high consumption of breast-milk
and complex carbohydrates (cereals/maize) between six
and nine months of age, with steady declines in breast-
feeding thereafter [20].
Details of the study methodology and procedures, and
characteristics of this community, have been previously
published [17,21]. Briefly, 373 infants were enrolled
between June 2003 and October 2004, with follow-up of
enrolled children ending in January 2006. Children were
excluded from enrolment if they received micronutrient
supplements in the previous month, if weight was below
60% of the median for age using NCHS references, [22] if
they had nutritional edema, if they had diarrhea for moreChhagan et al. BMC Public Health 2010, 10:145
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than seven days at the time of study enrollment, or if co-
enrolled in other intervention trials. Randomization was
performed after HIV status was determined. For children
HIV testing was done with a quantitative HIV RNA assay
(Nuclisens HIV-1 QT, Organon Teknika or Nuclisens
EasyQ HIV-1, Biomerieux, Boxtel, The Netherlands). For
maternal HIV status two ELISA tests were done (first
Vironostika HIV-1 Microelisa system and then Uni-Form
II plus O if the first test was positive, both Biomèrieux)
each of which had to be positive for HIV infection to be
diagnosed.
An allocation list was prepared using computer-gener-
ated random numbers and a block size of six. The manu-
facturer prepared numbered packs of tablets
corresponding to the allocation list. Assignment to the
three treatment arms was done separately for three
cohorts of children stratified by HIV status of child and
mother: HIV-infected children of HIV-infected mothers;
HIV-uninfected children born to HIV-infected mothers;
and HIV-uninfected children of HIV-uninfected moth-
ers. Investigators, study staff and participants were blind
to the treatment assignments.
None of the children received antiretroviral therapy
because of the unavailability of therapy for children in
both public and private clinics during the study period.
When antiretroviral therapy for children became avail-
able in clinics in the area in January 2005, all children
with HIV infection in the study were referred for evalua-
tion and initiation of therapy as appropriate.
Micronutrient supplements
There were three supplement arms, one of which con-
tained only 1250 IU of vitamin A. This served as the con-
trol group instead of a placebo arm because the standard
of care in South Africa at the time of the study was six-
monthly vitamin A supplementation to children below
the age of five years. The daily dose of vitamin A used in
the trial was equivalent to the 6-monthly high-dose sup-
plementation. The other two supplements contained 10
mg of zinc as zinc gluconate in addition to 1250 IU vita-
min A. The multiple micronutrient additionally con-
tained 0.5 mg each of vitamins B1, B2 and B6; 0.9 μg
vitamin B12; 35 mg vitamin C; 5 μg vitamin D; 6 mg vita-
min E; 10 μg vitamin K; 0.6 mg copper as cupric glucon-
ate; 150 μg folate; 50 μg iodine; 10 mg iron as ferrous
fumarate; and 6 mg niacin. All supplements were pack-
aged in identical blister packs of seven tablets. All trial
supplement tablets had the same color, form, texture and
taste. Caregivers were instructed to crush the tablets into
a small volume of porridge and ensure that the entire pre-
pared portion was consumed. Trained field workers made
weekly home visits to monitor compliance and to supply
study supplements. At each visit, the field workers
observed preparation and administration of the tablet.
Any tablets remaining from the child's previous supply
were counted and recorded. Use of any other micronutri-
ent supplements during the study was documented[17].
Children who were found to have hemoglobin below 10
g/dL during the routine testing performed on all study
participants were given therapeutic iron as per South
Africa Department of Health guidelines, which recom-
mend 6 mg/kg elemental iron daily in divided doses with
meals and continued for three months after hemoglobin
level reaches 10 g/dL.
Procedures
Length, head circumference, mid-upper arm circumfer-
ence and triceps skin-fold thickness were recorded by a
trained study nurse at enrolment and subsequently at
scheduled visits to the study clinic. Caregivers and infants
were asked to return for scheduled visits at 7, 8, 9, 12, 15,
18, 21 and 24 months of age to assess growth using
anthropometry[17]. Nurses were trained on standardized
anthropometric measurements according to the guide-
lines of the Dutch Growth Foundation[23]. An electronic
digital scale was used to measure weight to the nearest
0.1 kg. A Harpenden infantometer was used to measure
recumbent length to the nearest 0.1 cm (Holtain, Cry-
mych, UK). Intra-observer and inter-observer technical
errors of measurement for anthropometric data were pre-
viously reported for this trial and showed acceptably low
measurement error rates[21]. Hemoglobin determination
was done at the clinic by study nurses trained in the stan-
dardized use of a portable HemoCue system (Angelholm,
Sweden) that is also routinely used for measuring hemo-
globin in health services. Information on diarrhoea was
collected during weekly home visits[17].
Growth analyses
Length-for-age and weight-for-age Z-scores for each
child at each visit were computed using the WHO Child
Growth Standards[24]. A changing trend in Z-score over
time may represent growth faltering or catch-up growth
given the child's preceding Z-score. For growth assess-
ment the outcome measure was change in length-for-age
Z-score over 18 months. The main predictor included in
the analysis was treatment group. We used mixed effects
regression models using PROC MIXED in SAS V9.1 (SAS
Institute, Inc., Cary, North Carolina) to construct growth
curves for repeated measures of length-for-age Z scores.
Models that included treatment group, time since ran-
domization, a random-effect factor for children and an
interaction term for treatment by time were fitted using
maximum likelihood estimation. A spatial covariance
structure was used to model correlations within children.
These models had a better fit (as measured by Akaike's
Information Criterion) than those with compound sym-
metrical or unstructured correlations. A significant over-Chhagan et al. BMC Public Health 2010, 10:145
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all F-test for the treatment by time interaction at a type I
error level of 0.05 was used to decide whether there was
an effect of treatment on longitudinal growth. Stunting
was defined as a length-for-age Z-score below -2 [24].
Because previous meta-analyses have suggested a greater
response to micronutrient supplementation in stunted
children, we also examined effects of supplementation in
stunted children. For the main analysis second-order sta-
tistical interactions were tested between treatment group
and HIV cohort over time; these were considered signifi-
cant at p-value < 0.05. The growth curves modeled above
were then presented graphically by fitting smoothed
cubic splines to show the longitudinal trends of the sup-
plemented arms.
Analysis of effects on anemia
Anemia was defined as hemoglobin below 11 g/dL[25].
For this exploratory analysis, hemoglobin measurements
from two time-points - the start of intervention and 12
months later - were used to determine the effects of the
micronutrient supplementation. We used McNemar's
test to assess within group differences in the proportion
of study subjects with anemia at these two time points,
and one-way ANOVA was used to assess changes in
mean hemoglobin concentrations in the treatment arms.
These analyses were done separately for all subjects and
for those children who were anemic at baseline. Analyses
of treatment effects on anemia and hemoglobin effects
were confined to those subjects who had hemoglobin lev-
els available at baseline and at 12 months.
Statistical considerations
We estimated post-hoc power for our growth analyses
bearing in mind that the numbers of children in the HIV-
infected cohort were below the target determined by a-
priori sample size calculations. In the cohorts of HIV-
uninfected children we had adequate power using
repeated measures on subjects to detect an effect size of
0.3 Z-scores, which is comparable to what had been
observed in previous studies in the nutrition litera-
ture[26]. In the HIV-infected cohort, only an effect size
greater than 0.5 Z-scores could be detected. For the sec-
ondary analysis on hemoglobin and anemia we assumed
that there would be no meaningful difference between
t h e  c o h o r t s  o f  H I V - u n i n f e c t e d  c h i l d r e n  b o r n  t o  H I V -
infected mothers and uninfected children born to unin-
fected mothers so we combined these two cohorts of
HIV-uninfected children in the analysis. With 65 to 70
subjects per treatment arm and conducting one-way
ANOVA we had 90% power to detect differences in
hemoglobin change as small as 0.3 g/dL at a 0.05 signifi-
cance level. The small sample size of fourteen HIV-
infected children would not allow any meaningful analy-
ses on anemia to be conducted. The present trial was
designed to detect different effects among HIV cohorts
therefore analyses were stratified by HIV group. A poste-
riori exploratory analyses were also conducted to explore
the differential effect of interventions on two other rele-
vant sets of subgroups defined by stunting and diarrhea
incidence, based on prior literature describing subgroup
differences and biologic plausibility. The presence of
these subgroup effects was evaluated by testing for statis-
tical interaction. For these exploratory analyses second-
order statistical interactions between treatment group
and subgroup over time were considered significant at p-
value < 0.1.
Ethical review
The Ethics Review Committee of the University of Kwa-
Zulu-Natal and the Institutional Review Board of Tufts-
New England Medical Center both approved the study. A
Data Monitoring and Safety Board, established by the
National Institutes of Health, monitored conduct of the
trial. A parent or guardian for all children participating in
the study provided written informed consent.
Results
Information on length Z-scores at two or more occasions
was available for 317 (85%) of 373 children enrolled in the
study (Figure 1): 25 HIV-infected children; 135 unin-
fected children born to HIV -infected mothers and 157
uninfected children born to uninfected mothers. Baseline
hemoglobin measurements were available for 254 (68%)
of the 373 children, baseline and 12 month hemoglobin
measurements were available for 210 children (Figure 1).
The treatment arms were similar in baseline characteris-
tics (Table 1). There was no significant difference
between treatment arms in the proportion of children
who were lost to follow-up (including withdrawal or
death). Participants were compliant with ingestion of the
supplements 77% of the days they were enrolled in the
study with no difference in compliance detected between
treatment groups. Use of any other micronutrient supple-
ments during the study was rare. Ten children (five in the
VA arm, three in the VAZ arm and two in the MM arm)
received a dose of vitamin A other than the study inter-
vention. Fourteen children (eight in the VA arm, and
three each in the other two arms) received another multi-
vitamin during the study for an average duration of one
week.
At study entry, differences in length already existed
between HIV-infected and HIV-uninfected infants (Fig-
ure 2). Longitudinal growth trajectories also differed
between HIV-infected compared to HIV-uninfected chil-
dren, with the former showing severe declines over time
(P = 0.001 for cohort by time interaction). There was also
a significant statistical interaction of time, cohort and
treatment (P = 0.002). HIV-uninfected children born toChhagan et al. BMC Public Health 2010, 10:145
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infected mothers and those born to uninfected mothers
had similar growth trajectories during the trial. We there-
fore collapsed the HIV-uninfected cohorts into a single
group and stratified further analyses by HIV status,
namely HIV-infected versus HIV-uninfected. Among
HIV-uninfected children there was no observable differ-
ential effect of treatment on length-for-age Z score trends
(P = 0.37 for treatment by time interaction).
We detected an interaction between time, treatment
and stunting (P = 0.08). In the 62 children in all three
cohorts who were stunted at baseline the multiple micro-
nutrient arm showed, on average, a 0.7 Z-score improve-
ment in length-for-age Z scores over 18 months versus
declines of 0.3 in vitamin A plus zinc and 0.2 in vitamin A
arms. There was a significant interaction (P = 0.029)
between treatment and time in stunted children (Figure
3). The pattern of improved longitudinal growth was sim-
ilar when restricted to growth of 52 HIV-uninfected chil-
dren with stunting at baseline, and there was also
significant interaction (P = 0.027) between treatment and
time. There was no detectable effect of treatment on lon-
gitudinal growth in children who were not stunted at
baseline, including the cohort of 240 children who were
HIV-uninfected, even after adjusting for baseline length
Z-score.
A  s e p a r a t e  a n a l y s i s  o f  H I V - i n f e c t e d  c h i l d r e n  f o u n d
those receiving multiple micronutrient had a worse tra-
jectory than children in the other two intervention arms
(P = 0.042 for treatment by time interaction - Figure 4).
Because of the small number of HIV-infected children we
performed individual subject plots to detect influential
subjects who might have contributed to the unexpected
growth outcomes. These revealed that censorship, either
due to death or loss to follow-up, was associated with
preceding poor growth. Furthermore, this effect differed
between treatment arms. The multiple micronutrient
arm had longer follow-up per subject irrespective of the
preceding growth pattern. In the other two treatment
arms censorship was more likely to occur early for those
subjects that had declining Z scores. In HIV-infected
children mean baseline length Z-score was lower in the
group of censored children (-1.84, 95% CI -2.75, -0.92)
than in those who completed the study (-0.74, 95% CI -
1.60, 0.12). The missing data points for HIV-infected chil-
dren after loss to follow-up were therefore non-ignorable.
Furthermore, HIV-infected subjects who left the study
had a lower mean CD4 percentage at enrolment (15.6%,
95% CI 10.1, 21.1) than those who continued follow-up
(25.6%, 95% CI 15.8 35.5). The pattern of missing data
and participant attrition was not associated with preced-
ing growth or treatment arm in HIV-uninfected children.
Table 1: Characteristics of 373 children by treatment arm
Vitamin A (n = 124) Vitamin A + zinc (n = 123) Multiple micronutrients (n = 126)
HIV-infected childδ 9 (7.3) 11 (8.9) 12 (9.5)
HIV-uninfected child, HIV-
infected motherδ
52 (41.9) 52 (42.3) 50 (39.7)
HIV-uninfected child, HIV-
uninfected motherδ
63 (50.8) 60 (48.8) 64 (50.8)
Maleδ 72 (58.1) 61 (49.6) 60 (47.6)
Length-for-age Z score*† -0.65 (1.11) -0.64 (1.27) -0.71 (1.19)
Weight-for-age Z score*† -0.06 (1.37) 0.06 (1.32) 0.05 (1.34)
Weight-for-length Z score*† 0.51 (1.38) 0.58 (1.30) 0.63 (1.38)
Children with stunting at baselineδ 26 (21.0) 20 (16.3) 23 (18.3)
Hemoglobin g/dL* 10.0 (1.29) 10.12 (1.24) 9.99 (1.19)
Duration of observation in months, 
median (25th - 75th centile)
16.6 (9.3-17.9) 16.5 (8.2-17.7) 15.7 (5.8-17.5)
Children receiving iron therapy during 
study periodδ
28 (22.8) 26 (21.1) 29 (23.2)
*Values are mean (standard deviation)
δ Values are n (%)
† As a Z-score of WHO International Growth References [24]Chhagan et al. BMC Public Health 2010, 10:145
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Figure 1 Participant flowchart.
Figure 2 Longitudinal changes in length-for-age Z score by HIV cohort (n = 317). (P = 0.001 for cohort by time interaction).
= HIV-infecteda
«« +,9-uninfected children born to HIV-infected mothersb
= HIV-uninfected children born to uninfected mothersb
acohorts with different superscripts are significantly different from each other (P < 0.05)
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Exploratory analyses of the effect of supplementation on 
growth among children with repeated diarrhea
We examined the effects of treatment in subgroups expe-
riencing differing diarrhea incidence. We created catego-
ries based on diarrhea rates with cut-offs being four or six
episodes respectively for the high diarrhea rate group. An
interaction was detected between time, treatment and
diarrhea rate (P = 0.09). Multiple micronutrients supple-
mentation and addition of zinc to vitamin A ameliorated
the effects of repeated diarrhea episodes on growth in the
cohorts of HIV-uninfected children (Figure 5). The pro-
tective effect of multiple micronutrients was observed in
those with diarrhea incidence above four episodes per
year and especially so in those experiencing more than six
episodes of diarrhea per year (Figure 5). In children expe-
riencing more than six episodes per year the multiple
micronutrient arm experienced a zero Z-score change in
length over time while the vitamin A and vitamin A plus
zinc arms experienced 0.6 and 0.5 Z-score declines
respectively (P = 0.006 for treatment by time interaction).
Figure 3 Longitudinal changes in length-for-age Z score in children who were stunted at baseline, all cohorts combined (n = 62). (P = 0.029 
for treatment by time interaction).
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Figure 4 Longitudinal changes in length-for-age Z score in HIV-infected children (n = 25). (P = 0.042 for treatment by time interaction).
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We were unable to conduct similar analyses for HIV-
infected children because of the limited number of chil-
dren in this group.
Exploratory analysis of the effect of supplementation on 
anemia and hemoglobin
The prevalence of anemia was 78.4% at baseline and
61.6% after 12 months respectively. In HIV-uninfected
children, and in all cohorts combined, paired comparison
at the two time points showed that the vitamin A and
multiple micronutrient arms had significantly fewer sub-
jects with anemia at 12 months versus baseline (Table 2).
We were unable to explore changes among HIV-infected
children due to limited sample size. The proportion of
subjects receiving off-protocol therapeutic iron for ane-
mia during the trial was similar across treatment arms
(T able 1). Fewer children continued to be anemic at 12
months in the multiple micronutrient arm than in the
other arms, but the difference between arms was not sta-
tistically significant (Table 2). For all children, combining
those who were anemic and non-anemic at baseline, the
vitamin A plus zinc arm tended to have a lower mean
increase in hemoglobin compared to the other two arms
after adjusting for cohort and baseline hemoglobin (Table
3).
Discussion
Daily multiple micronutrient supplementation that
included vitamin A and zinc, when compared to vitamin
A alone or to vitamin A plus zinc, improved longitudinal
growth over 18 months in children who were stunted at
baseline. This is in keeping with the findings of a meta-
Figure 5 Longitudinal changes in length-for-age Z score among HIV-uninfected children experiencing. a) > 4 episodes of diarrhea peryear (n 
= 74). (P = 0.007 for treatment by time interaction). b) > 6 episodes of diarrhea per year (n = 34). (P = 0.067 for treatment by time interaction).
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Table 2: Proportions of study subjects with anemia1 at baseline and 12 months by HIV status and treatment arm
Cohort Treatment arms n Subjects with anemia n (%)2
Baseline 12 months P value†
HIV-uninfected 
(n = 196)
Vitamin A only 64 49 (76.6) 38 (59.4) 0.0278
Vitamin A + zinc 67 51 (76.1) 42 (62.7) 0.0833
Multiple micronutrients 65 54 (83.1) 38 (58.5) 0.0017
All cohorts 
(n = 210)
Vitamin A only 68 52(76.5) 40 (58.8) 0.0186
Vitamin A + zinc 71 54 (76.1) 46 (64.8) 0.1306
Multiple micronutrients 71 60 (84.5) 43 (60.6) 0.0011
1 Anemia is defined as hemoglobin level below 11 g/dL [25]
2 Analysis includes subjects with hemoglobin available at baseline and twelve months
†Within group changes from baseline (McNemar Test)Chhagan et al. BMC Public Health 2010, 10:145
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analysis that found that multiple micronutrients, but not
vitamin A or iron alone, improved longitudinal growth in
children[26]. Previous findings [7] in conjunction with
the present study suggest that the failure of zinc alone, or
zinc and vitamin A, to improve growth may be related to
the coexistence of other nutrient deficiencies, such as
iron, thus limiting the response to zinc supplementation
when used alone. This is further supported by a trial in
Chinese children that found multiple micronutrients with
zinc to be better than zinc alone in improving growth
velocity[27]. The differences across trials in various geo-
graphic regions may be attributable to differences in
prevalence of stunting, iron and other micronutrient defi-
ciencies (such as vitamin D), or to infectious disease bur-
den and spectrum.
Exploratory analyses found that multiple micronutri-
ents, when compared to vitamin A alone or with zinc,
ameliorated the effect of recurrent diarrhea on stunting.
Zinc has been shown to be effective in the case manage-
ment of diarrhea - reducing the duration of the diarrhea
episode and improving growth thereafter[28]. To our
knowledge the protective effect of zinc, or multiple
micronutrients, against the growth retarding effects of
repeated episodes of diarrhea has not been demonstrated
in previous trials. The finding from this study that multi-
ple micronutrient supplementation ameliorates the effect
of diarrhea on growth suggests that progressive stunting
in children with repeated diarrhea may be related to defi-
ciencies of multiple nutrients. This finding, arising from
exploratory analyses, needs further investigation in larger
studies.
The relatively small number of HIV-infected children in
the study, and the non-ignorable pattern of missing data
in this group, limits our ability to detect effects and make
inferences for the cohort of HIV-infected children. All
HIV-infected children with available CD4 counts who
dropped out of the study either due to death or loss to fol-
low-up had severe HIV disease based on immunologic
criteria. The worse growth pattern seen in the multiple
micronutrient arm is thus most likely related to the lon-
ger follow-up of stunted children in this arm rather than
any impact of a particular micronutrient formulation.
One may anticipate better cohort retention and very dif-
ferent outcomes in the presence of antiretroviral therapy.
Our findings emphasize the need for evaluating how pat-
terns of missing data and severity stratification may influ-
ence outcomes in trials involving HIV-infected children.
While all three treatment arms had reductions in the
proportion of children with anemia over 12 months, sup-
plementation with multiple micronutrients tended to
achieve the greatest reduction in anemia. This is sup-
ported by findings from a large multi-centre trial of mul-
tiple micronutrients that included South African[5];
Vietnamese [11]; Indonesian [29]; and Peruvian
infants[9]. In the Indonesian trial daily supplementation
with multiple micronutrients was better than supplemen-
tation with iron alone in improving the hemoglobin of
anemic infants. This occurred despite a lack of effect of
multiple micronutrients in reducing morbidity or
improving growth.
In this trial, anemia and hemoglobin change were not
included as a priori hypotheses. Children with a hemo-
globin level below 10 g/dL received iron treatment while
continuing the study intervention. We were unable to
examine whether the micronutrients prevented anemia
because there was already a high prevalence of anemia at
baseline. While similar numbers of children in each arm
received iron treatment, fewer children in the multiple
micronutrient arm remained anemic at the end of 12
months compared to the other arms. This may be due to
the presence of iron in the multi-micronutrient formula-
tion, resulting in an effectively higher total daily dose of
iron than what would have been ingested through the
therapeutic iron alone. The relatively smaller increment
Table 3: Change in hemoglobin in all subjects stratified by presence of anemia at baseline
n Mean change in hemoglobin g/dL, mean (95% CI)1 [n per treatment arm]
Vitamin A only Vitamin A + zinc Multivitamins Overall P2
All subjects 210 0.59 (0.22, 0.97)b [68] 0.17 (-0.20, 0.54)a [71] 0.62 (0.26, 0.98)b [71] 0.06
Anemic
at baseline
166 0.99 (0.56, 1.41) [52] 0.49 (0.07, 0.91) [54] 0.93 (0.54, 1.31) [60] 0.10
Not anemic 44 -0.92 (-1.81, -0.02) [16] -1.12 (-2.00, -0.25) [17] -0.48 (-1.56, 0.59) [11] 0.49
1 Adjusted for baseline hemoglobin and cohort
2 ANOVA F-test
Values in the same row with different superscripts are significantly different from each other (P < 0.05)Chhagan et al. BMC Public Health 2010, 10:145
http://www.biomedcentral.com/1471-2458/10/145
Page 10 of 11
in hemoglobin in the vitamin A plus zinc arm compared
to vitamin A alone suggests a possible inhibitory effect of
zinc on iron absorption. The multiple micronutrient arm
showed similar improvements in mean hemoglobin to the
vitamin A arm despite containing zinc. It is possible that
the additional micronutrients alleviated the negative
effect of co-administration of iron and zinc. This is an
important observation, albeit arising from exploratory
analyses, that a combination of micronutrients may
improve childhood morbidity while minimizing the
potential negative biologic interactions between these
nutrients.
The effect of the micronutrient supplements on anemia
and hemoglobin were not among the primary aims of the
study, and thus the results of this analysis, as with any
post-hoc analysis, have to be interpreted with caution.
While similar numbers of children in each treatment arm
received therapeutic iron the possibility of unmeasured
confounding still remains. However, we think that this
may improve generalizability to programmatic conditions
where anemic children would receive iron therapy as
standard of care. This is especially relevant to our trial,
where children were enrolled for 18 months and exposure
to other interventions - such as supplemental iron - is
likely under non-trial conditions. The trial of zinc and
multiple micronutrients in Peru by Penny et al. [30] also
reported out-of-protocol administration of therapeutic
iron to large numbers of subjects in whom anemia was
detected. Interestingly, that study also found a pattern of
lower hemoglobin responses in the group that received
zinc only as opposed to group who received zinc plus
multiple micronutrients.
Conclusions
In summary, these findings suggest that daily multiple
micronutrients added to vitamin A supplementation in
infants and children may be useful in improving growth
in children who are stunted or who have repeated diar-
rhea, and thus as a public health intervention in commu-
nities with a high prevalence of either stunting and
recurrent diarrhea. The significant effect of multiple
micronutrients compared to vitamin A alone that was the
control group, or to vitamin A plus zinc, on longitudinal
growth in this study is important for other African coun-
tries where zinc supplementation alone was not found to
reverse stunting. The question of individual targeting for
stunted children versus universal administration of multi-
ple micronutrients to children in high-risk environments
still needs to be resolved. Further evidence is needed to
confirm the beneficial effects of micronutrients on ane-
mia, and to determine whether similar benefits apply to
HIV-infected children - especially those receiving antiret-
roviral therapy, which is now the standard of care. While
exploratory analyses suggest an inhibitory effect of zinc
on iron absorption, the co-administration of other micro-
nutrients may negate this inhibitory effect.
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